zonisamide capsule

INDICATIONS AND USAGE Zonisamide capsules are indicated as adjunctive therapy in the treatment of partial seizures in adults with epilepsy.

glenmark pharmaceuticals inc., usa

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] off label use` `[3] fatigue` `[4] nausea` `[5] dyspnoea` `[6] diarrhoea` `[7] pain` `[8] vomiting` `[9] death` `[10] pyrexia`

6 years ago

CAPSULE BLUE G24 25

HOW SUPPLIED

ZONISAMIDE capsules USP are available as 25 mg, 50 mg and 100 mg two-piece hard gelatin capsules.

ZONISAMIDE capsules USP are available in bottles of 100 and 500 with strengths and colors as follows: Dosage Strength capsule Description Pack NDC # 25 mg white opaque body and light blue cap with ‘G 24’ printed on the cap and ‘25’ printed on the body in black ink. 100 count with child-resistant closure 68462-128-01 500 count 68462-128-05 50 mg white opaque body and yellow gold cap with ‘G 24’ printed on the cap and ‘50’ printed on the body in black ink. 100 count with child-resistant closure 68462-129-01 500 count 68462-129-05 100 mg white opaque body and light green cap with ‘G 24’ printed on the cap and ‘100’ printed on the body in black ink. 100 count with child-resistant closure 68462-130-01 500 count 68462-130-05 Store at 25°C (77°F), excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Store in a dry place and protect from light. Medication Guide available at www.glenmarkpharma-us.com/medguides Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430 Questions? 1 (888) 721-7115 www.glenmarkpharma-us.com October 2020 logo

More pills like CAPSULE G24 25

Related Pills

Zonisamide zonisamide 100 MG Oral Capsule

Glenmark Generics Inc., USA

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site